4-(n-maleimido)benzyltrimethylammonium and glycoprotein e2, hepatitis c virus

4-(n-maleimido)benzyltrimethylammonium has been researched along with glycoprotein e2, hepatitis c virus in 1 studies

Compound Research Comparison

Studies (4-(n-maleimido)benzyltrimethylammonium)	Trials (4-(n-maleimido)benzyltrimethylammonium)	Recent Studies (post-2010) (4-(n-maleimido)benzyltrimethylammonium)	Studies (glycoprotein e2, hepatitis c virus)	Trials (glycoprotein e2, hepatitis c virus)	Recent Studies (post-2010) (glycoprotein e2, hepatitis c virus)
19	0	2	892	16	290

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Boo, I; Drummer, HE; Fraser, J; Poumbourios, P	1

Other Studies

1 other study(ies) available for 4-(n-maleimido)benzyltrimethylammonium and glycoprotein e2, hepatitis c virus

Article	Year
Hepatitis C virus (HCV) envelope glycoproteins E1 and E2 contain reduced cysteine residues essential for virus entry. The Journal of biological chemistry, 2011, Sep-16, Volume: 286, Issue:37 Topics: Alkylating Agents; Alkylation; Cysteine; HEK293 Cells; Hepacivirus; Humans; Oxidation-Reduction; Protein Multimerization; Quaternary Ammonium Compounds; Recombinant Proteins; Tetraspanin 28; Viral Envelope Proteins; Virus Internalization	2011

Article

Year

Hepatitis C virus (HCV) envelope glycoproteins E1 and E2 contain reduced cysteine residues essential for virus entry.

The Journal of biological chemistry, 2011, Sep-16, Volume: 286, Issue:37

Topics: Alkylating Agents; Alkylation; Cysteine; HEK293 Cells; Hepacivirus; Humans; Oxidation-Reduction; Protein Multimerization; Quaternary Ammonium Compounds; Recombinant Proteins; Tetraspanin 28; Viral Envelope Proteins; Virus Internalization

2011